Fisher And Paykel Healthcare Corpo dividend and valuation
$37.69Change from previous close: +0.96%Absolute change: +$0.36
Valuation
Fisher And Paykel Healthcare Corpo paid $0.44 per share in dividends over the last 12 months (yield 1.2%). Last ex-dividend date: June 22, 2026. The P/E ratio is 53.8. The average price target of 8 analysts is $36.93.
Data as of October 7, 2026
Valuation multiples
- Market cap
- $22.17B
- Enterprise value
- $21.6B
- P/E (trailing 12 months)
- 53.8
- Forward P/E
- 42.8
- PEG
- 43.6
- Price/book
- 12.9
- Price/sales
- 9.60
- EV/EBITDA
- 28.4
- EV/revenue
- 9.36
Profitability and growth
- Gross margin
- 63.7%
- Operating margin
- 28.7%
- Net margin
- 20.3%
- ROE
- 23.4%
- ROA
- 14.7%
- Revenue growth (year over year)
- 14.0%
- Earnings growth (year over year)
- 14.3%
Financial health
- Total cash
- $461.1M
- Total debt
- $146.1M
- Debt/equity
- 0.07
- Current ratio
- 2.32
- Quick ratio
- 1.62
Dividends
- Annual dividend per share
- $0.44
- Dividend yield
- 1.2%
- Payout ratio
- 62.2%
- Ex-dividend date
- June 22, 2026
Analysts and estimates
- Average price target
- $36.93
- Median price target
- $37.84
- High price target
- $43.62
- Low price target
- $24.63
- Analysts with a price target
- 8
- Forward EPS
- $0.88
- EPS estimate, current year
- $0.95
Shares and trading
- Beta
- 0.88
- Average volume
- 368.33K
- Shares outstanding
- 588.27M
- Float
- 584.99M
- Institutional ownership
- 38.5%
- Insider ownership
- 3.7%